C

Curza

18 employees

Curza is a small-molecule therapeutics company provides proprietary drugs focused on infectious diseases and oncology.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
antimicrobial
Bacteria
Health Care
Biofilms
Small Molecules
Therapeutics
lyme disease
cystic fibrosis
Antibiotics
tuberculosis
Antibiotic resistance

Date founded

2013

Funding rounds raised

Total raised

$5.3M

from 5 investors over 5 rounds

C

Curza raised $5.3M on July 25, 2019

Investors: REPAIR Impact Fund

C

Curza raised $4M on February 16, 2018

Investors: CARB-X

C

Curza raised $4.3M on July 1, 2017

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

C

Curza raised $2.4M on May 12, 2016

Investors: united-states-department-of-defense

C

Curza raised $5M on November 14, 2015

Investors: Clarke Capital Partners

FAQ